Return to homepagePandemic Pact

The Adaptive COVID-19 Treatment Trial (ACTT)

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N91019D00024-0-759102000010-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2025

  • Known Financial Commitments (USD)

    $40,199,082

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    BETH BASELER

  • Research Location

    United States of America

  • Lead Research Institution

    LEIDOS BIOMEDICAL RESEARCH, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

To support randomized, controlled clinical trials to evaluate the safety and efficacy of investigational antiviral drugs against COVID-19.